[go: up one dir, main page]

WO2002036488A1 - Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation - Google Patents

Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation Download PDF

Info

Publication number
WO2002036488A1
WO2002036488A1 PCT/RU2000/000533 RU0000533W WO0236488A1 WO 2002036488 A1 WO2002036488 A1 WO 2002036488A1 RU 0000533 W RU0000533 W RU 0000533W WO 0236488 A1 WO0236488 A1 WO 0236488A1
Authority
WO
WIPO (PCT)
Prior art keywords
xenon
κsenοna
treatment
πρi
business
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2000/000533
Other languages
English (en)
Russian (ru)
Inventor
Nikolai Nikolaevich Aleinikov
Andrei Nikolaevich Aleinikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/RU2000/000533 priority Critical patent/WO2002036488A1/fr
Priority to RU2002134464/15A priority patent/RU2232711C1/ru
Priority to AU2001236259A priority patent/AU2001236259A1/en
Publication of WO2002036488A1 publication Critical patent/WO2002036488A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A61L2/186—Peroxide solutions
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B15/00—Peroxides; Peroxyhydrates; Peroxyacids or salts thereof; Superoxides; Ozonides
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B23/00—Noble gases; Compounds thereof
    • C01B23/0005—Compounds of noble gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps

Definitions

  • the method of radiating xenon The method of radiating xenon.
  • the methods of radiating the xenon are known to be heated by heating the mixture with no more than 2 at a temperature of 300-500 ° C at a pressure of 0.5-1.5
  • the target product obtained by such a method is a high content of the compound and xenophosphate, but the device itself is low.
  • 35 can only be used for calculating milligram quantities of the product.
  • the methods of calculating the range of xenon are known, including the contacting of the product being cleaned with metal fluids and the transfer agent. ⁇ réelle On the other hand, metal fluids are used as potassium phosphates.
  • reagents that are used for contacting the product themselves may be the source of contaminants.
  • Hazardous or hydroxyfluoride xenon is a result of the safety of the hydrolysis and the productiveness of the process does not provide (Mar., Deliverable, -18, 8.
  • the end result of the targeted product and the hydraulics of the xenon and the theoretical yield is 33%, the practical one is no more than 15%, but
  • 25 xenon solution xenon 5 g of hexane xenon is placed on the bottom of a flask with a capacity of 200 ml. Thoroughly cool with liquid nitrogen and add 50 ml of water. The mixture is slowly heated to a room temperature. The process of adding water and heating the mixture is often caused by explosions. The resultant solution added 8 g of magnesium oxide. The garden separates the product from the glass filter of the middle area. Then, the decomposition of the oxide is consecutively discontinued through a tank with a hydration system of 50-100 mesh. and 20 percent mesh dioxide. The front of the dishwasher is washed 4 ⁇
  • the cost of this method is the low output of the hydroxide.
  • the limiting stage of the process 35 sa is the stage of the formation of the xenon hexane. ⁇ m ⁇ le ⁇ s ⁇ e ⁇ b * ⁇ 3 or ⁇ chnee i ⁇ nn ⁇ e s ⁇ edinenie ⁇ er 5 + ⁇ 4 " ⁇ b ⁇ azue ⁇ sya for v ⁇ emya ⁇ lazhdeniya ⁇ ea ⁇ a vy ⁇ d ⁇ m tselev ⁇ g ⁇ ⁇ du ⁇ a with 55- 92%.
  • guanidines which are the beginning of short-circuiting, are complex organic compounds of the type of chlorephenyl-dihydanedhexane or coke-alkylene diamine. Guanidines are active in respect of small and medium-sized microorganisms, with the exception of tuberculosis microbes. Guanidines don't
  • the product is prepared for processing and treatment, and the product is free of charge.
  • the preparations of this group have a wide range of anti-microbial effects: bactericidal, tuberculocidal, virulicidal, fungicidal, and higher
  • aldehyde-containing drugs lack of and low risk of lack of metal (no risk of failure).
  • Chemical disinfectants and sterilizing agents are known on the basis of ethanol, alcohol, isopropanol (alcohol).
  • alcohol alcohol
  • isopropanol alcohol
  • a healthy 70% Russia
  • bactericidal disease urethrombosis
  • the following products are known: Industrial aerosol (France), Bacillus plus (Germany), Grostan (Germany), Inci-
  • Chemical disinfecting and sterilizing phenolic substances are known. They include Lysol (USD), 5 Lobrubana (USD), Umotsid (Germany), Umotsid-2000 and others (1).
  • the drugs possess bactericidal, tuberculocidal, virulicidal and fungicidal properties.
  • the phenol-containing substances are widely used in the disinfectant, because the phenome-
  • Izves ⁇ ny is ⁇ lz ⁇ vanie for ⁇ bezza ⁇ azhivaniya ⁇ ve ⁇ n ⁇ s ⁇ ey ⁇ n ⁇ amini ⁇ vanny ⁇ vege ⁇ a ⁇ ivn ⁇ y or s ⁇ v ⁇ y ⁇ m ⁇ y mi ⁇ - ganizm ⁇ v in meditsins ⁇ y, mi ⁇ bi ⁇ l ⁇ giches ⁇ y or ⁇ ischev ⁇ y ⁇ - myshlenn ⁇ s ⁇ i s ⁇ eds ⁇ va on ⁇ sn ⁇ ve v ⁇ dn ⁇ g ⁇ ⁇ as ⁇ v ⁇ a ⁇ e ⁇ sen ⁇ na ⁇ a
  • the manufacturer which provides a total of 40% (total) of the product
  • the individual plant has a strongly pronounced biocidal effect.
  • Particularly strong antimicrobial properties of xenon dihydrogen in comparison with calcium and calcium are the most susceptible to water and are most susceptible to
  • Imm ⁇ biliz ⁇ vannye an ⁇ ise ⁇ i ⁇ i ( ⁇ asilni ⁇ v ⁇ .P .. "S ⁇ av ⁇ chni ⁇ ⁇ an ⁇ ise ⁇ i ⁇ e, publishing v ⁇ ⁇ ysshaya sh ⁇ la, Bela ⁇ ussiya, ⁇ ins ⁇ , s ⁇ 67 -.. (2) S ⁇ edi an ⁇ ise ⁇ i ⁇ v ⁇ isli ⁇ elnym me ⁇ anizm ⁇ m deys ⁇ viya ⁇ bladayu ⁇ ⁇ e ⁇ e ⁇ is v ⁇ d ⁇ da, ⁇ aliya ⁇ e ⁇ mangana ⁇ and gal ⁇ geny ⁇ is-.
  • the negative side ⁇ 0 2 is the instability of some of the disinfections, shortage of actions, reduction or loss of
  • the genogens When combined with hydrogen, the genogens form the genalogenoids, with metals - the genogens. Halogens are not directly connected with acid; they are not directly connected to indirect reactions.
  • Linaderm (Croatia)
  • the drug is known to have been found to have been found to have a strong acidity (3%, 5%, 5%, 5%). Boric acid products use in case of dermatitis, accelerated illnesses, shallow burns, chronic obstructive diseases, it is extremely difficult ⁇ the last time ⁇
  • the drug is known to have been on the basis of the presence of diabetes ( ⁇ irritable tissue ⁇ )))))), the input of which is 2–5% of the percentage
  • hypoplasia is accumulated in the skin, causing irritation of the mucous membranes and skin (pages 96 - 2).
  • the product is disposed of on the basis of the product when it is disposed of by light, in conjunction with metals, organic matter, and clicks.
  • the product in the past, there has been a decrease in the physical sensitivity of microorganisms to the consumption of water and the stability of the appliance.
  • the drug is known to have been used on a basic conversion of acid, which has a direct effect on maternal and proliferative diseases,
  • Antiphormin is changed as an antiseptic in the form of 1 - 50% of solutions for the treatment of local pathological processes, especially in the presence of ulcers.
  • the mechanism of action and the toxicity are similar to the situation (p. 70 - 2). 14
  • urethra a food product
  • urea a product of urea and urea, which is discharged from a food product.
  • They use instead of 3% fresh water - 5 flaxseed products for rinsing, siphoning, rinsing, ran.
  • the beneficial effect of 0.25-1.0% is significant, the hygienic one is unchanged (pages 76 - 2).
  • Inorganic food products are known. 1) 5% alcohol. 2) 10% alcohol. ⁇ as ⁇ v ⁇ y ⁇ imenya- th yu ⁇ sya ⁇ a ⁇ an ⁇ ise ⁇ i ⁇ ⁇ i gigieniches ⁇ y and ⁇ i ⁇ u ⁇ giches ⁇ y ⁇ b ⁇ ab ⁇ e ⁇ u ⁇ , ⁇ e ⁇ atsi ⁇ nn ⁇ g ⁇ ⁇ lya for ⁇ ila ⁇ i ⁇ i in ⁇ itstsi ⁇ vaniya non b ⁇ lshi ⁇ ⁇ v ⁇ ezhdeny tsel ⁇ s ⁇ n ⁇ s ⁇ i ⁇ zhi and ⁇ a ⁇ zhe ⁇ azd ⁇ azhayuschee and ⁇ vle ⁇ ayuschee s ⁇ eds ⁇ v ⁇ . If you are using a large amount of food or drink, it may cause toxic or allergic infections.
  • the lugola is in good condition (it is better), which is used only for the acute inflammatory process of the nose, which is pleasant to the heart (2).
  • This appliance does not include food, food, dihydroxyxypropane, food, and also a larger group of food.
  • the potent activity of the iodine is associated with the presence of an inferiority ( ⁇ 3 " ) rather than a small incidence of the disease.
  • the devices of the devices are the possible manifestations of stable forms of bacteria of the medical devices (2).
  • the potassium permanganate ( ⁇ AIN ⁇ ⁇ ⁇ 5 ⁇ 5 ka) is known; oral and pharynx (0.01-0.1%), antiseptic bathtubs for the newest. Disadvantages: Dispensers of a pre-dresser, hot pots will open the laundry and the binder, suction in
  • a circle causes a method of hemoglobbing (pages 85 - 2).
  • Biologically active substances are known to be used in commercially available products for the storage of food products, for the storage of food products in medicine, and foodstuffs.
  • Biologically active supplement is known to be a short-lived supplement
  • a well-known kromet is known - an emulsified geriatric krem, which contains both the basic and, as a rule, biologically active substances, it is a significant difference from the outside world. It has a simple, portable, hydraulically, opaque and anti-oxidative effect ( ⁇ 2032397).
  • a balm for hair, including biologically active substances, is known - it is synthesized and phylozalysine and structure-forming
  • a good hygienic product is known to be hazardous, in turn, biologically active substances are used as a means of biological activity (oil) 17
  • amniotic fluid for women to consume transplants (20 ⁇ 2053671).
  • Izves ⁇ n ⁇ is ⁇ lz ⁇ vanie for ⁇ chis ⁇ i zhid ⁇ i ⁇ , gaz ⁇ vy ⁇ and sy- ⁇ uchi ⁇ s ⁇ ed ⁇ ⁇ sid ⁇ v az ⁇ a, se ⁇ y, and ugle ⁇ da ⁇ ganiches ⁇ i ⁇ ⁇ - sichny ⁇ vesches ⁇ v ⁇ islenie ⁇ si ⁇ an ⁇ v ul ⁇ a ⁇ i ⁇ le ⁇ vym radiation Niemi in ⁇ isu ⁇ s ⁇ vii ⁇ imiches ⁇ g ⁇ ⁇ eagen ⁇ a in v ⁇ zbuzhdenn ⁇ m s ⁇ s ⁇ ya- SRI ( ⁇ 2,115,463).
  • the diluted gas mixtures are unstable with the air and the content of the gas in them is reduced when stored (thus, at a temperature of 20 ° C, 40% is discharged in 10).
  • a narrow area of the process of water discharging and discharging is the adaptation of the unit for mixing the zone with water and water.
  • Chemical substances are known - oxidizing agents and super-oxidizing agents, which are only in the form of therapeutic agents for a wide range of active substances.
  • ⁇ S ⁇ P ⁇ ⁇ e ⁇ e ⁇ is v ⁇ d ⁇ da is ⁇ lzue ⁇ sya in ⁇ sn ⁇ vn ⁇ m, ⁇ a ⁇ ⁇ m ⁇ nen ⁇ s ⁇ eds ⁇ v for dezin ⁇ e ⁇ tsii ⁇ n ⁇ a ⁇ ny ⁇ lenses s ⁇ eds ⁇ v u ⁇ da for ⁇ zhey, v ⁇ l ⁇ sami, v ⁇ di ⁇ in s ⁇ s ⁇ av zubny ⁇ ⁇ as ⁇ and ⁇ a ⁇ zhe ⁇ iv ⁇ zacha ⁇ chny ⁇ s ⁇ eds ⁇ v for ⁇ ed ⁇ v ⁇ ascheniya za ⁇ azheniya zhen- z ⁇ of tires ⁇ ⁇ l ⁇ v ⁇ g ⁇ ⁇ a ⁇ ne ⁇ a.
  • it is used to expedite the removal of ethanol from the country ( ⁇ 5759539).
  • a one-stop treatment of diabetes is another oxidizing agent that is used in medical treatment as a medical device.
  • ⁇ n is ⁇ lzue ⁇ sya for treating b ⁇ lny ⁇ ⁇ zhi ⁇ eniem ( ⁇ 2,008,905) gn ⁇ yny ⁇ gaym ⁇ i ⁇ v ( ⁇ 5 2014816), ⁇ z ⁇ vy ⁇ and vulga ⁇ ny ⁇ ug ⁇ ey ( ⁇ 2,014,838, ⁇ I 2,019,192) ⁇ bli ⁇ e ⁇ i ⁇ uyuschi ⁇ zab ⁇ levany nizhni ⁇ ⁇ nechn ⁇ s ⁇ ey ( ⁇ 2,014,848) ⁇ i ⁇ de ⁇ my ( ⁇ 2,029,552) ⁇ niches ⁇ g ⁇ gn ⁇ yn ⁇ g ⁇ end ⁇ b ⁇ n ⁇ i ⁇ a ( ⁇ 2070045), nes ⁇ etsi ⁇ iches ⁇ i ⁇ zab ⁇ levany leg ⁇ i ⁇ ( ⁇ 2,071,774, ⁇ 2,085,196) mening ⁇ v
  • Resin (0 3 ) since it is a medicinal product that is actively used in medicine for the treatment of medicinal products, acute plasma diseases, and medical treatment of patients
  • ⁇ z ⁇ n ⁇ a ⁇ zhe is ⁇ lzue ⁇ sya: in ⁇ aches ⁇ ve s ⁇ imulya ⁇ a ⁇ ege- w ne ⁇ atsii ⁇ echeni ( ⁇ 94,008,835) for ⁇ vysheniya ⁇ ab ⁇ s ⁇ s ⁇ bn ⁇ s ⁇ i ⁇ ganizma ( ⁇ 94,008,836) de ⁇ si ⁇ atsii ⁇ ganizma ( ⁇ 94017960, ⁇ 96,100,223) and ⁇ e ⁇ tsii eg ⁇ s ⁇ s ⁇ yaniya ( ⁇ I 96122812).
  • ⁇ UNDERSTANDING is widely used as a medical remedy for the treatment of serious diseases ( ⁇ 4196726,
  • Calcium permanganate is yet another oxidizing agent, which is used in medicine as a medicinal product. ⁇ aliy ⁇ Root ⁇ man-
  • 35 ghana possesses a universal system of microbicidal activity. It is effective in relation to bacteria, piles, viruses, spores. The mechanism of action is in the deoxidation of organic matter from the microbial cell, but there is always a squirrel. Calcium removers in concentrate from 0.02% to 0.1% are used for washing
  • the drug is known to have been treated with idoxuridine ( ⁇ ⁇ ⁇ ⁇ , ⁇ ⁇ ⁇ )), which has a direct depressing effect on the treatment of non-infections. It is used as an operational practice as
  • Idoxuridine 15 non-hazardous external components due to viruses caused by a viral load ( ⁇ ⁇ réelle ⁇ ICS ⁇ ICS york CS-40 or ⁇ ⁇ ⁇ ). Idoxuridine expects to have an irritant effect on everyone, cause pain, flushing, eyelids, allergic reactions or medical treatment (product treatment).
  • Drugs are known that indicate a curative and preventive effect on a general infection.
  • drugs are known that indicate a curative and preventive effect on a general infection.
  • t ⁇ a ⁇ derivatives of amadantana - fugidantan
  • Izves ⁇ n ⁇ ⁇ iv ⁇ vi ⁇ usn ⁇ e s ⁇ eds ⁇ v ⁇ (zayav ⁇ a ⁇ S ⁇ / ⁇ 92 / 00170, 09.09.92) s ⁇ s ⁇ yaschee of deys ⁇ vuyuscheg ⁇ ⁇ m ⁇ le ⁇ sa na ⁇ iev ⁇ y s ⁇ li na ⁇ ivn ⁇ y D ⁇ with ⁇ livalen ⁇ nym me ⁇ all ⁇ m, vyb ⁇ annym of me ⁇ all ⁇ v ⁇ , ⁇ e, S ⁇ , ⁇ , ⁇ and ⁇ , vzya ⁇ ymi in m ⁇ ln ⁇ m s ⁇ n ⁇ shenii 10-
  • the essence of the invention is to achieve this result - 0 in the result of the production of xenon, 23
  • the pressure is 10 to 40 m. (0.7 - 1.2), and the following 5 stabilization of the target product on the walls of the reactive vessel at a temperature of 0 ° C to minus 196 ° C.
  • stabilization is carried out at a temperature of minus 70 ° C - minus 80 ° C.
  • Interaction in the vessel is from a cylinder assembly with a cylinder with a diameter of 1 to 2 between the voltage and voltage between the electrics.
  • Non-technical result, in part, of the method of calculating the xenon impurity, is excluded from the high-output product.
  • the product to be cleaned Before contacting, the product to be cleaned is disposed of in a non-hazardous product, and after contacting the consumer, the product has to be cleaned.
  • the highest yield of the target product can be achieved by the non-hazardous use of non-hazardous water.
  • the method of radiation is xenon xenon.
  • the technical result achieved in the process of obtaining xylene xenon is to increase the yield of the target
  • Means for disinfection, sterilization, antiseptics, 15 degassing, detoxification Means for disinfection, sterilization, antiseptics, 15 degassing, detoxification.
  • the device for disinfection and sterilization is 20% non-profitable and has a significant interest rate
  • 15 cations contain an aqueous solution of a complex of xenon hexane and a concentration of boron in the concentration of 0.000001% to 0.5%.
  • the biological supplement for food is provided with its own aqueous product of a diffuser or xenon oxide.
  • a biologically active additive for the sale of a business plan provides a unique or physiological growth rate of 0.5% at a percentage of 0.00%.
  • a biologically active food supplement for food preserves produces a unique water supply of 25% in a percentage of 0%, 0.0000%.
  • Additive for the storage of fresh meat provides a variety of xenon oxide in gas - gas or gaseous phase or acid oxide in the form of calcium oxide or sodium hydroxide
  • xenon oxide in gas - gas or gaseous phase or acid oxide in the form of calcium oxide or sodium hydroxide for the storage of fresh meat in a hermetic preparation, there is a special food product of 0.05%.
  • a biologically active additive for products containing a commercially available product results in a wholly or non-hazardous product of a percentage of 0.3%
  • the technical task of the invention in part pharmaceutical pharmaceuticals is the search for chemical substances - oxidizing agents, ⁇
  • 25 shedding and healing action which contains xenon dif- ferent, or xenon x-ray, or xenon xenotide, or xenotropic xenotide with a percentage of 0.5%.
  • An optional version of a combination of a separate diluent or a xenon oxide or an accelerated xenocene, 15 or an oxygen complex is an optional version of a combination of a separate diluent or a xenon oxide or an accelerated xenocene, 15 or an oxygen complex.
  • This medication can be used for the treatment and treatment of type T, C and C, for the treatment of viral diseases of the skin, for the treatment of cures for the treatment of
  • composition for the detoxification of an organism which contains a variety or a xenon, or an increase in a percentage of a disease of a% 0
  • the compo- sition will result in an aqueous dispersal of the disease or x-ray or x-ray or x-ray or x-ray or x-ray or x-ray of the x-ray or x-ray or x-ray of the x-ray or x-ray of the x-ray.
  • This arrangement may contain an aqueous dispersant or xylene xenon, or a dispersant or xenon oxide in a physiological environment.
  • Cooled distilled water connected to a separate manual tube, e.g. All the details of the installation are performed from materials that are stable to the operation of the factory.
  • a smoldering discharge of a variable frequency of 50 Hz is used.
  • High voltage is created with the help of a high-voltage transformer.
  • the voltages and voltages control the milliammeter and the voltmetry, respectively.
  • the voltage and voltage regulate the power supply, the battery, and also the pressure in a separate pipe.
  • the pressure is measured at the entrance to the reactive vessel with a standard manometer.
  • the synthesis is carried out in a cylindrical vessel from a plastic assembly and with an interconnection to the electrical outlet. 1: 2 under static conditions and the constant supply of a gas mixture in the process.
  • the degree of conversion of the initial reagents to the target product is 98%.
  • the speed of production of a variety of xenon can be reached up to 200-250 g / h when using a diameter of 60-80 mm, a pressure of 50 m and a pressure of 35-40 mm.
  • the xenon diffuser contains an explosive impurity (up to 2%) of the xenon test. This problem may be resolved by the elimination of xenon in the absence of moisture (up to 3%) and the subsequent 35% cleaned water.
  • stabilization is carried out at a temperature of 5 minus 70 ° C - minus 80 ° C.
  • EXAMPLE 2 The conditions are the same as in the case of-1 ° 1, but it is preferable that there is a stable stabilization at a temperature of minus 70 ° ⁇ - minus 80 ° ⁇ .
  • Example 3 The conditions are the same as in case of ⁇ ° 2, but it is predominantly connected to a vessel with an external power supply.
  • Example 4 The best synthesis mode is xenon with a density of 99.5% and a yield of 60 g / h: a diameter of 50 mm, a pressure of 30 mm, and a voltage of 30 mm, voltage is 2.5 mm mm, the temperature of stabilization of the target product minus 80 ° ⁇ .
  • Example 5 The original product of Ge 2 in the amount of 10 g is 98% of Ge- 2 , 1.9% Ge 4 and 0.1% ⁇ (according to the data of the analytical analysis).
  • P ⁇ tsess ⁇ chis ⁇ i za ⁇ lyuchae ⁇ sya in ⁇ e ⁇ eg ⁇ n ⁇ e ⁇ i ⁇ mna ⁇ n ⁇ y ⁇ em ⁇ e ⁇ a ⁇ u ⁇ e is ⁇ dn ⁇ g ⁇ ⁇ du ⁇ a with ⁇ a ⁇ ami dis ⁇ illi ⁇ vann ⁇ y v ⁇ dy in ⁇ liches ⁇ ve, ne ⁇ b ⁇ dim ⁇ m for ⁇ ln ⁇ g ⁇ gid ⁇ liza ⁇ e ⁇ 4.
  • 35 ⁇ e ⁇ eg ⁇ n ⁇ a not ⁇ zv ⁇ lyae ⁇ ⁇ azdeli ⁇ ⁇ iziches ⁇ imi me ⁇ dami ⁇ a ⁇ mixture ⁇ e ⁇ ⁇ e ⁇ and 2, and ⁇ a ⁇ ⁇ b ⁇ azuyuschiysya m ⁇ le ⁇ ulya ⁇ ny ⁇ m ⁇ le ⁇ s ⁇ e ⁇ ⁇ e ⁇ * 2 4, in view bliz ⁇ s ⁇ i ⁇ iziches ⁇ i ⁇ ⁇ a ⁇ ame ⁇ v, n ⁇ vz ⁇ yvcha ⁇ aya mixture ⁇ az ⁇ ushae ⁇ sya vzaim ⁇ deys ⁇ viem with ⁇ a ⁇ ami v ⁇ dy and ⁇ sleduyuschey ⁇ e ⁇ eg ⁇ n ⁇ y ⁇ du ⁇ v ⁇ ea ⁇ tsii ⁇ Waste water in the usual 0 way. 35
  • the yield of xenon is 90% (9.0 g). According to the data of a physical analysis, at least 99.5% of the data are available (here, we make up 0.5%).
  • the process for calculating the xenon variety is included in the addition of the original product to the cold water supply, which contains ice water
  • the yield is 75%.
  • the number of available data is
  • Example 7 The original product of 10 g of xenon dihydride, containing explosive admixture of xenotone 2.5%, is a naturally occurring exudate of hydrogen sulphide.
  • the yield of xenon is 62% (6.2 g). The number is not less than 99.5%. Add ⁇ no more than 0.5%. 36
  • This method is suitable for the calculation of products that contain impurities of a xenon hydroxide, which is usually exploded when hydrated.
  • the number of the target product is not less than 99.5%
  • the method of radiation is xenon xenon.
  • 35 is ⁇ ally di ⁇ ida ⁇ altsiya and ⁇ e ⁇ a ⁇ b ⁇ a ⁇ a ⁇ altsiya di ⁇ ida or magnesium and magnesium ⁇ e ⁇ a ⁇ b ⁇ a ⁇ a ⁇ delyayu ⁇ ⁇ il ⁇ vani- it on s ⁇ e ⁇ lyann ⁇ m ⁇ il ⁇ e and ⁇ myvaniem ⁇ l ⁇ dn ⁇ y dis ⁇ illi ⁇ - vann ⁇ y v ⁇ d ⁇ y ⁇ is ⁇ all ⁇ v ⁇ luchayu ⁇ tselev ⁇ y ⁇ du ⁇ . 37
  • Example 9 The method of hydrolysis of adduct ⁇ réelle * 6 * ⁇ 3 , similar to Example 1. Hydrolyzes 30 g of adduct, at + 15 ° ⁇ . Target sales of 92%.
  • Hydrolysis operation takes advantage of practical additions of the last substance (approximately 3 minutes).
  • ⁇ - the result of the obtained product is char- acteristic of the following absorption bands: 780-820 cm “1 , proper communication due to He- ⁇ , 1620, 3400 cm “ 1 communication ⁇ - ⁇ .
  • EXAMPLE 12 Filling unit with agitator with a capacity of 1000 ml Holds 200 ml of a 30% output of a single unit 38
  • Crystals of calcium or magnesium sulfide are separated by filtering on a glass filter and washing out a large, distilled water product.
  • 15 And - the resultant product is characterized by the following absorption bands: 780-820 cm “1 , proper communication ⁇ réelle- ⁇ , 1620, 3400 cm " 1 communication ⁇ - ⁇ .
  • Example 13 The method of hydrolysis of Ge 6 is similar to Example 5. Hydrolyzed 20 g of the substance in 50% solution of the acid solution at a temperature of + 15 ° C. Target product sales 93%.
  • Hydrometeorological unit 6 in 2-6 !quaternary ammonium salt
  • a 14-liter flask of 100 ml capacity holds 30 ml of 4 ⁇ water, which contains 360 mg (2.0 mmol) of 0 e0 3 .
  • ⁇ 0.9 g add 1.8 g ⁇ réelle 0 2 * 8 ⁇ 2 0 (4 mmol).
  • the precipitated precipitate 0 is centrifuged, washed twice with ice-cold water 39
  • Example 15 The conditions of the synthesis are the same, but the process conducts at a temperature of 3 ° C. The prevalence of the national economy in the sample is 98.0%.
  • Example 16 The synthesis conditions are the same, but the process leads to a temperature of 20 ° ⁇ . The incidence of the incidence of depression in the sample is 95.0%.
  • Example 17 A flask of 100 ml capacity holds 50 ml of 6 ⁇ water, which contains 3.6 g of water, 2 0 2 * 8 ⁇ 2 0 (8 15 mmol). At 0 ° ⁇ , at ⁇ 0.5 g, add 1.66 g of Ge ⁇ 4 (8 mmol). . After 1.0 hours of stirring at 0 ° ⁇ , the precipitated precipitate is separated by centrifugation, the rinses are washed with ice-cold water and dried in a vacuum at 10 ° ⁇ for 2 hours.
  • Example 18 A small flask with a volume of 100 ml holds 50
  • the method of obtaining a complex of a hexane with xenon with a transformer of boron includes the synthesis of a hexafluoride xenon complex with 40 hydrogen fluids in a liquid fluid in the system: 40
  • the limiting stage of process 5 is the stage of the formation of xenon hexane.
  • Example 20 The conditions for the synthesis of the complex are the same, but the reaction is carried out at 423 ⁇ ⁇ 2 hours. Target product sales 93%. A total of 97%.
  • Example 22 The conditions of the complex synthesis are the same, but the reaction takes place at 403 ⁇ ⁇ 3 hours. Target product sales 93%. A total of 95%.
  • Example 23 On an autoclave, a hydroxide solution of xenon 1226.5 mg (5 mmol) in an anhydrous hydrogen chloride of 100 ml was added and added a gaseous sulfur dioxide of 29 mm (5 mm).
  • Medium 2 for disinfection, sterilization, antisynthesis, detoxification and degassing of hazardous substances - hazardous infections result in a risk of 1.5% 15
  • the percentage of xenon in the concentration is not more than 0.03% with the added conversion of hydrogen in the concentration not more than 0.05%.
  • Medium 10 for disinfection and sterilization of contact lenses - water or physiological conversion of xenon in 5% concentration is not more than 0.05%.
  • Medium 11 for the disinfection and sterilization of contact lenses - an aqueous solution of xenon concentration in the concentration of not more than 0.05%.
  • Xenon Diffuser is a second-hand solid material that is stable when stored in a large area of the car. 25 Xenon oxide - in the form of a 5% solution, is stable for 5 years.
  • Transporting water - a 98% concentration ensures that there is a good deal of discounts, which can be stored in a dark herbal court for ten years. In the event of a disruption to the storage area, it is a hard part of the product that is inaccessible to storage space.
  • Processing and disinfecting Compounds 1, 2, 3, 4 and 5 are at least 5 minutes by spraying, bypassing or bypassing.
  • Imperfect 1 in a gas or gas phase without and with the use of compressed gases may be used for disinfection and disruption of the accident
  • Medium 2 can be used as a large antiseptic for the sterilization of the hands of the patient and the disinfection of the medical device, and also the treatment This means in 5 minutes completely suppresses bacteria, dysfunctions, viruses.
  • Compounds 1, 2, 3, 4, 5, 6, 7, 8, 9 exhibit bactericidal, virucidal, phygocidal and sortsocide properties and are effective for the disinfection and sterilization of an instrument
  • 25 will be at least 1 cm.
  • Medium 1 or Medium 6 in connection with medical devices.
  • dezin ⁇ e ⁇ tsii products ⁇ ba ⁇ e ⁇ y, mi ⁇ b ⁇ v, and vi ⁇ us ⁇ v g ⁇ ib ⁇ v d ⁇ s ⁇ a ⁇ chn ⁇ i ⁇ 10 - minu ⁇ n ⁇ y vyde ⁇ zh- z ⁇ ⁇ i in S ⁇ eds ⁇ va ⁇ 6 and 7.
  • 35 is also for disinfection and sterilization of microbes and bulk contaminated agricultural products, including agricultural products, as well as food products.
  • Mi 9 - 12 in addition to the basic task of eliminating microorganisms, additional effects are achieved.
  • Medium 9 - 12 have high detergent properties in respect of both organic and non-urban substances and various pollutants. It is noted that the processing of commercially available contact lenses by these means contributes to the improvement of their property due to the washing-up of the In addition, the low-cost concentra- tions of Devices 9–12 in the scope of contact lenses make them more stylish. Sterilization is carried out by using a single or multi-pronged contact lens in the medium 9 - 1 1 for more than 5 minutes after the next
  • Products 1, 6, 17 process the product as a result of washing off the walls of the building, spraying the product, or gas phase.
  • the amount of time needed to process the product with a volume of 2.5 to 16 m 3 is 15 to 30 minutes.
  • Parts 1 and 2 may be used to disinfect and sterilize medical devices and their components from microbial contamination.
  • Immediately 16 may be used for disinfection and sterilization of different rotations below 8.
  • Inventory 13, 14, 15 produces products such as aquatic products, non-aqueous products by washing the wall, or by spraying the product with or without spraying
  • Agents 18, 19, 20, and 21 may be used for the uninstallation of hazardous infections, strong poisonous substances, and non-toxic substances. THESE MEDICINES POSSESS THE EXPRESSLY BICIDAL ACTION.
  • Example 25 The biocidal activity of the drug from 1 (Black) was tested in relation to the liquid biologically active substance that was harmful to the cause of the drug.
  • EXAMPLE 26 The competitive activity of the Medium ⁇ ° 1 (K ⁇ 2 ) was due to the agroculture of the Agrarian Culture 8 and Sh. step ⁇ Table ⁇ - 4 is shown for complete destruction of the 47
  • Example 27 The biocidal activity of the product ⁇ ° 2 ( ⁇ réelle ⁇ ) was justified by the reduction of dry plague.
  • Example 28 The competitive activity of the product ⁇ ° 2 ( ⁇ flower ⁇ ) was due to the agroculture of the United States cultural Council. ⁇ £ é and ⁇ 6633. ⁇ table - ⁇ ”6 is indicated that a complete destruction of the indicated culture results in a 30-minute instantaneous profit, which is 2% 2% 5 .
  • Example 29 Biocidal activity of the drug ⁇ ° 16 ( ⁇ réelle- ⁇ réelle ⁇ ⁇ )
  • Example 31 The biocidal activity of the Medium ⁇ ° 17 ( ⁇ 6 - ⁇ 3 ) was amended because of the loss of food due to the risk of serious injury.
  • ⁇ ⁇ ab- face - ⁇ z9 ⁇ azan ⁇ , ch ⁇ ⁇ ln ⁇ e ⁇ bezza ⁇ alsivanie mixture nas ⁇ u ⁇ ae ⁇ z ⁇ ⁇ i 5- ⁇ i minu ⁇ n ⁇ y e ⁇ s ⁇ zitsii, ⁇ i ⁇ ntsen ⁇ atsii S ⁇ eds ⁇ va ⁇ ° 17 0.01% and mi ⁇ bn ⁇ y nag ⁇ uz ⁇ e 2,0x10 b, and 0.05% - ⁇ ln ⁇ e for ⁇ bezza ⁇ alsivanie 3 min.
  • EXAMPLE 32 Sickness activity of Medium ⁇ ° 17 (June 6- ⁇ ) was due to agribusiness cultivation
  • nizm ⁇ v z ⁇ a ⁇ u ⁇ s ⁇ ssiz a ⁇ eaz, z ⁇ a ⁇ ku ⁇ s ⁇ ssiz ⁇ geit ⁇ shae, ⁇ zei- ⁇ t ⁇ az eag ⁇ its ⁇ za, ezse ⁇ sYa s ⁇ , asshtz ziYShez, ⁇ g ⁇ e ⁇ z ⁇ i1 ⁇ a ⁇ z, sa ⁇ a aSh ⁇ agz, e ⁇ eg ⁇ as ⁇ eg, z ⁇ -ei ⁇ a ⁇ i ⁇ s ⁇ g, ⁇ gazeez ( ⁇ -6, ⁇ - yie ⁇ a, e ⁇ ez) ⁇ sch ⁇ .
  • Table ⁇ »11 shows the results of the action of Means 2, 3 and 4 in dilutions of 0.02% to 0.002% for daily cultures in 1 ml. Cultivated 10 units. (10 9 cells in 1 ml). Operation 5 min.
  • Example 34 ⁇ Table- ⁇ ”12 The operating modes are shown without
  • Example 36 The table ⁇ 4 shows the aspects of sterilization of endoscopes of Medium ⁇ ° 1 (Mar 2 ), Medium ⁇ ° 3 (Mar 0 3 ), Medium ⁇ ° 16 Medium ⁇ ° 17 (He ⁇ 6 - ⁇ 3 ).
  • the regimes of sterilization of endoscopes are shown for comparison with 5 sterilizing compounds of Sidex (S ⁇ P ⁇ ), Lysophores - 3000 (Germany), ⁇ lds ⁇ (France).
  • Example 41 For dozens of people, research has been done on the elimination of alcohol addiction. As a result of research, it is found that the working concentra- tion neutralizes completely
  • Example 42 The method of treatment and the treatment of type ⁇ , ⁇ 1, ⁇ 2, ⁇ and C means of treating mucous diseases or drug-related diseases 51
  • EXAMPLE 43 A method for treating angina pectoris, acute ulcers are included in that 2 times per day are sprayed,
  • Example 46 The method of treating conjunctivitis is included in that, which is stored in the conjunctival sac 2-3 times, in addition to this, there is a significant increase in the incidence of the disease.
  • Example 48 The method of extracting plasma from plasma after the addition of plasma results in the addition of a percentage increase of 10% (an increase in interest rate of 0%).
  • Example 50 A method of treating painful, nonspecific lung diseases includes medical treatment and pain
  • Example 53 A method for treating a neurology is concluded,
  • Natural phenomena may be used in conditions of any kind of self-sustaining institution.
  • Example 55 The method for the treatment of inflammatory diseases of internal diseases of women and of male patients 5 includes a 2–3% treatment of the disease.
  • Example 56 For the quick removal of carbon monoxide (a lot of carbon) from the economy, they add to the physical phosphorus concentration a percentage of 0.1% of the concentration of 0.1%.
  • EXAMPLE 58 In the treatment of liver cirrhosis, a transverse aqueous solution of xenon 3 times per day is added (concentration on dry material is 50 mg per 100 kg).
  • EXAMPLE 59 For the prevention of complications of a non-inhalation-like disorder (anesthetizing effect), there is a pain in 10-20 minutes
  • Example 60 Oxide and diphtheidum xenon may be used as a means to stimulate a multiphase
  • Patsien ⁇ male 52 g ⁇ da in ⁇ ezul ⁇ a ⁇ e ⁇ ab ⁇ y with gaz ⁇ b ⁇ aznym ⁇ m and ⁇ ganiches ⁇ imi ⁇ sichnymi s ⁇ edine- z ⁇ niyami in ⁇ echenie 20 le ⁇ ⁇ luchil zab ⁇ levanie - ⁇ an ⁇ ea ⁇ i ⁇ ⁇ dzhe- lud ⁇ chn ⁇ y gland with n ⁇ yashimi b ⁇ levymi ⁇ schuscheniyami in ⁇ echenie day na ⁇ ushen gaz ⁇ vy ⁇ bmen, b ⁇ li not giving the opportunity to save at night. The condition worsened on a bad day.
  • Example 62 A male patient is 48 years old (patent). P ⁇ lu- chill ⁇ zh ⁇ g ⁇ av ⁇ y s ⁇ ny face and ⁇ zh ⁇ g vnu ⁇ enney s ⁇ ny ⁇ av ⁇ y ⁇ u ⁇ i ( ⁇ is ⁇ ) sha ⁇ v ⁇ y m ⁇ lniey (change ⁇ ed ⁇ ani ⁇ eley on vys ⁇ - v ⁇ l ⁇ n ⁇ y ⁇ ds ⁇ antsii v ⁇ v ⁇ emya g ⁇ zy) Siln ⁇ e b ⁇ leznenn ⁇ e and s ⁇ ess ⁇ v ⁇ e s ⁇ s ⁇ yanie (on ⁇ u ⁇ e and face ⁇ b ⁇ az ⁇ valis ⁇ uzy ⁇ i). Le-
  • EXAMPLE 63 The treatment of cynocunjunctivitis was generally given in the case of natural foods of the territory. ⁇ early disease general
  • Example 64 A treatment was provided for a dog, a German dog, and an infestation of a mucous membrane of the gastric area. An increase in ulcerative pain was observed. The dog had chewed dry, and foamy saliva was released from the oral cavity. The lively behavior was unhindered, it was said to be good. Treatment was achieved by the growth of the health of the dog, with an increase in xenon concentration of 0.05% 3 times per day. ⁇ -
  • the 15th dose for sprouting was 20 ml of solution. On the 5th day, discharge from the urinary tract decreased, the odor disappeared, on the 10th day the ulcers healed.
  • Example 65 The treatment of a dog, a German dog, and a quick inflammation of a few whelps was achieved.
  • EXAMPLE 66 A trial of the therapeutic properties of a xenon soda and a xenon transplant for 180 mice of the ⁇ line was carried out. on a model of salmonous infection in combination with a sharply expressed glasic invasion. Patient changes were observed in the liver: plain white cysts 1-3 mm in size were observed, small (with a pin head) whitish whites were detected
  • Example 67 The treatment of a dog is given, food - methis, 3 years, weight 65 kg. Diagnosis: gastric enlargement, the cause of disintegrated sticks. The treatment was administered by administering a direct-to-other aqueous solution of xenon xenon 0.07% at 20 ml
  • the food products of the connection on the basis of xenon are introduced at the stage of production (for grocery products, framing) or at the stage of packing in the factory (for).
  • the product is put in a gas medium, xenon is used, or is processed in a gas medium, or is consumed by a consumer or a consumer
  • Antimicrobial fabrics with chemically-linked hexahedrally are effective way of fighting with gnome infection and are used for the manufacture of linen, for personal hygiene
  • ⁇ Pi ⁇ is ⁇ lz ⁇ val ⁇ s ⁇ a ⁇ zhe an ⁇ imi ⁇ bn ⁇ e underwear s ⁇ de ⁇ - z ⁇ zhaschee ⁇ imiches ⁇ i associated ge ⁇ sa ⁇ l ⁇ en for ⁇ ila ⁇ i ⁇ i gn ⁇ ynich ⁇ vy ⁇ zab ⁇ levany ⁇ zhi people, dli ⁇ eln ⁇ e v ⁇ emya na ⁇ - divshi ⁇ sya in ge ⁇ me ⁇ ichn ⁇ zam ⁇ nu ⁇ y ⁇ ⁇ mescheniya ⁇ (on ⁇ ablya ⁇ ⁇ , ⁇ smiches ⁇ i ⁇ ⁇ ablya ⁇ , bi ⁇ m ⁇ le ⁇ sa ⁇ and d ⁇ ugi ⁇ s ⁇ ets ⁇ be ⁇ a ⁇ ).
  • HEXAXULO, phenylpropylene, 6U 6-14-136-76 contains 5 5,7,7,8 - tetraxibody ( ⁇ ) paraxyn in a concentration of 102 mg / kg.
  • Hexacylprophene the technical reserve is at 6-14-896-86 - a dose of 1 mg / kg is assimilated.
  • Water purification improves the taste of water, discolours food, water and wastewater, reduces the incidence of water and water consumables. poisons in non-toxic foods, increases the amount of acid, 5 phthous acid in water and destroys bacteria, viruses, fungi, microbes.
  • 2,4,5-cyclic acid which itself is an insecticide and a fungicide.
  • 2,4,5-thirophenic acetic acid obtained from 2,4,5-thirophenol is an effective herbicide.
  • the intensive herbicidal effect of the group of drugs is the acid, the salts and the effects of the inhibition of the disease.
  • 20 Derivative 2,4,5-glucose group - 2,4,5-glucaniline is a valuable product in the synthesis of narcotic drugs.
  • Acid compounds of xenon xylene oxide xenon (Xe0 3 ), xenon xylene oxide (xeon ⁇ ).
  • Pe ⁇ sen ⁇ na ⁇ y ⁇ e 4 ⁇ e0 6 wherein ⁇ e - ⁇ a ⁇ i ⁇ ny schel ⁇ chn ⁇ g ⁇ ⁇ da, 2n ⁇ a, ⁇ +, ⁇ + S ⁇ + 2 ⁇ e ⁇ e0 6 wherein ⁇ e - ⁇ a ⁇ i ⁇ ny schel ⁇ chn ⁇ zemel- 35 n ⁇ g ⁇ ⁇ da Ca +, ⁇ +, ⁇ a + ( ⁇ 4 ) 4 ⁇ réelle0 6 - the transfer of ammonia and ⁇ ( ⁇ réelle0 6 ) 3, transfer of aluminum.
  • Xenon Diffuser (Black 2 ) is a solid, crystalline, with a loss of 4.5 mm ⁇ . ct. ⁇ and temperature 25 ° ⁇ .
  • the specific weight of the xenon dif- ferent is 169.3 grams, the melting temperature is 141 ° ⁇ , the xenon temperature is not decomposed to a temperature of 500 ° ⁇ .
  • the xenon dif- ferent is disposed of in acetyl- The xenon range is over 99.5%. Higher rates are not available, the main addition is only ⁇ . Stability of the substance of xenon
  • Xenon diarrhea has a high biocidal activity in the presence of low-cost biocide in the presence of an excruciating drug.
  • 35% of the processing time is 5 minutes, 0.1% and the time of processing is 5 minutes, and the process is instantaneous and the concentration is 0.3%.
  • My xenon diffraction is 1 to 40 minutes. After a predetermined period of time, the process was neutralized and their neutralization was carried out (2 réelle 2 ⁇ 2 0 3 .5 ⁇ 2 0) in relation to a 1: 9 ratio. Then they dispensed seeding on healthy dietary food products (SCS) at a rate of 5 0.1 ml per cup of investigational dilutions. The cups were cooked for 72 hours at a temperature of 37 ° C (depending on the type of biological product). In parallel, we sent a bacteriological panel of the investigated suspension (without processing of the xenon). The data obtained were processed statistically with an increase of 95%.
  • SCS healthy dietary food products
  • Oxide xenon (Chest) (molecular weight 179.3 g). It is stored in the form of a 5% water supply and can be stored at room temperature for more than 5 years in a hermetic container and is safe in
  • the number of products of xenon xenon is at least 99.7%.
  • the dilution method is used to concentrate on the application. Studies of biocidal activity of one of the products of xenon xenon in the presence of a relieved dry plague vaccine have been carried out.
  • blowing microorganisms ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ,,,,,,,,,,,, , , ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66
  • Percussion solid crystalline white color The salinity in water is around 0.025 ⁇ at 25 ° ⁇ , the solubility of saline is 0.003 ⁇ in 0.1 nectamate of salmon and 0.0005 ⁇ in 0.5 ⁇ of salary. Thermostatic stability
  • the complex of the xenophosphorus xenon with a translucent bordea is a solid 40-minute white color, and does not have any acceleration 64
  • Solubility in water is 0.25 ° C at 25 ° C, but it is hydrolyzed by a high proportion of bicarbonate, which is highly toxic and non-hazardous.
  • Di ⁇ id ⁇ sen ⁇ na ( ⁇ e ⁇ 2) ⁇ i ⁇ sid ⁇ sen ⁇ na ( ⁇ e0 3) ⁇ e ⁇ se- n ⁇ na ⁇ na ⁇ iya ( ⁇ - ⁇ e ⁇ b) ⁇ m ⁇ le ⁇ s ge ⁇ sa ⁇ ida ⁇ sen ⁇ na with ⁇ i ⁇ - ⁇ id ⁇ m b ⁇ a ( ⁇ e ⁇ 6 » ⁇ 3) for ⁇ sn ⁇ ve, ⁇ y ⁇ s ⁇ zdany ⁇ a ⁇ matsev ⁇ iche- w
  • the widespread benefits of a wide range of activities have a small toxicity to other oxidizing agents and suppressing agents used in medicine.
  • toxicity of the product is made up of PDA-1.4 mg ⁇ m 3 , LD ⁇ 50-0.2 mg ⁇ kg., It is toxic,
  • mice in mice did not cause irritation. Apart from the application, there were no significant changes in the size of the main operating devices.
  • the experiment was administered for 2 weeks with daily exposure without 5 subsequent rinses of the preparation.
  • the study of the process of dissociation of the medium after large-scale conditions under conditions of a 2-week experiment on mouse diseases did not reveal any visible clinical manifestations or changes in the changes. Fundamental shifts that are valued at the loss of exposure, taking into account the total exponent of muscular disabilities and the effects of 19
  • the 20 human terms added water or physiological conversion of xenon concentration from 3.3 ⁇ S 5 5 ⁇ to 3.3 ⁇ S "2 ⁇ (0.006 - 0.6%). After 30 minutes and 24 hours, after the addition of the substance, an electric mixture was released. Prior to the concentration of the xenon xenon 3.3 x 10 "2, no changes in the protein composition were observed
  • albumin In addition to albumin, we added water or physiological solution of xenon in the concentration of 2.1 xYU "6 % of 3, 3% " 2 ⁇ (0.0004 - 0.6%). After 30 minutes and 24 hours, the mixture was emitted. When the concentration of xenon xenon 3.3x10 "2 ⁇ (0.6%) was observed, the albumin line disappeared, but did not resume after 24 hours.
  • 35 petroleum products include a xenon and / or a xenon and / or a xenon diaphragm in the form of a separate gas or oil distillate. They may be introduced into the body by external, internal, internal, muscular, inhalation, or application to 67
  • Xenon Dioxide, Xenon Tungsten Oxide and Potassium hydroxide are free to use and can be used in the pharmacy
  • the best available products are 5, which do not use toxic gases or toxic products, or use them.
  • the above described systems are the formation of which is not directly accessible at the first stage of communication with + communication.
  • the development of an oxide of xenon is not possible due to the thermodynamic instability (it is apparent that there is a decrease in the rate of
  • hydroxylamines and ammonium oxide which are further oxidized to nitrogen and water.
  • Cyanides are widely used in electroplating, in chemical technology 5 and the extraction of gold from poor minerals.
  • THESE TECHNOLOGIES REQUIRE ESSENTIAL WATER AND TOXIC MIXTURES.
  • the primary intermediate products of the interaction of xenon with water are oxides of oxidation at a rate of + 2, + 4,
  • the high oxidative and sterilizing properties of xenon are determined by the formation of an intermediate-reactive acid-base
  • non-hazardous intermediate compounds are hydrolyzed with further oxidation of the intermediate gas-hydroxide hydrolysis particles
  • the disinfecting and sterilizing properties of xenon are associated with a high oxidatively-viable potential, with a high output of a high-impedance
  • xenon compounds are hepatoprotectives, i.e. the drugs that protect the organism of hepatotoxic drugs,
  • 15 C is the initial density of the infection, the rate per cm 2 (average value).
  • Table- ⁇ The biocidal activity of xenon xenon in response to a resuspended dry plague vaccine.
  • ⁇ IS strain ⁇
  • Table - ⁇ 10 The accelerated activity of the complex of xenon with xenophosphate, depending on the concentration and time of exposure. Comparison in the front line is shown to be indicative of the reactivity of the substance.
  • SIGNIFICANT FOX (DR. 26) Table - a15- Comparative table for the sterilization of gas and a medical device for medical use, formaldehyde, xenotide, xenotoxide, a drug
  • the disinfectant disinfection method 300 ml per 1 m 3 of processed material for enteric and infectious infections and 500 ml for 1 m 3 process.
  • Viral infections - diphtheria, scaritis, meningic infection.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux procédés de fabrication de difluorure de xénon, de trifluorure de xénon, de perxénonate de sodium, du complexe hexafluorure de xénon - trifluorure de bore ainsi que l'utilisation de ces composés et des compositions sur leur base en tant qu'agents de désinfection, de stérilisation, de dégazage, de détoxication et comme agents antiseptiques. Ces composés peuvent s'utiliser comme additifs bioactifs, compositions pharmaceutiques et produits de recyclage pour déchets toxiques. Les agents de désinfection, de stérilisation, de dégazage, de détoxication et les agents antiseptiques, ainsi que les compositions pharmaceutiques à base de difluorure de xénon et / ou de trifluorure de xénon et / ou de perxénonate de sodium et / ou de l'additif d'hexafluorure de xénon avec du trifluorure de bore s'utilisent dans une vaste gamme de concentrations, comme solution aqueuse ou solution biologique mais également en phase gazeuse. Lors de l'utilisation, ces agents ne causent l'apparition d'aucun produit de décomposition toxique, sont sans danger pour le personnel médical et ne manifestent aucune activité toxique.
PCT/RU2000/000533 2000-10-28 2000-10-28 Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation Ceased WO2002036488A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/RU2000/000533 WO2002036488A1 (fr) 2000-10-28 2000-10-28 Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation
RU2002134464/15A RU2232711C1 (ru) 2000-10-28 2000-10-28 Способ получения дифторида ксенона, способ его очистки от взрывоопасных примесей и его использование
AU2001236259A AU2001236259A1 (en) 2000-10-28 2000-10-28 Method for producing oxygen and fluorine containing compounds of xenon and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2000/000533 WO2002036488A1 (fr) 2000-10-28 2000-10-28 Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation

Publications (1)

Publication Number Publication Date
WO2002036488A1 true WO2002036488A1 (fr) 2002-05-10

Family

ID=20129587

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2000/000533 Ceased WO2002036488A1 (fr) 2000-10-28 2000-10-28 Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation

Country Status (3)

Country Link
AU (1) AU2001236259A1 (fr)
RU (1) RU2232711C1 (fr)
WO (1) WO2002036488A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2325188C1 (ru) * 2006-08-15 2008-05-27 Общество с ограниченной ответственностью "КСИАН" (ООО "Ксиан") Применение ксенона для сохранения антиоксидантных свойств облепихового масла
RU2455227C1 (ru) * 2010-12-23 2012-07-10 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Способ получения дифторида ксенона
RU2673844C1 (ru) * 2018-04-04 2018-11-30 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Способ получения комплексного соединения состава 2XeF6xMnF4

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192016A (en) * 1962-12-18 1965-06-29 John G Malm Xenon hexafluoride and method of making
GB1056657A (en) * 1965-04-27 1967-01-25 Tech Gase Werke Berlin Veb Process for the preparation of fluorides of xenon and krypton
SU497222A1 (ru) * 1974-04-22 1975-12-30 Отделение ордена Ленина института химической физики АН СССР Способ получени перксенонатов
SU1560468A1 (ru) * 1988-03-09 1990-04-30 Институт Общей И Неорганической Химии Им.Н.С.Курнакова Ан Ссср Способ очистки дифторида ксенона
SU1699904A1 (ru) * 1989-11-04 1991-12-23 Отделение Института химической физики АН СССР Способ получени гексаоксоксеноната натри
SU1699903A1 (ru) * 1989-11-04 1991-12-23 Отделение Института химической физики АН СССР Способ получени водного раствора триоксида ксенона
RU2065488C1 (ru) * 1992-03-20 1996-08-20 Всесоюзный Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ Моющее средство для отмывки полимерной поверхности и способ отмывки
WO2000064495A1 (fr) * 1999-04-27 2000-11-02 Aleinikov, Nikolai Nikolaevich Agents de desinfection et de sterilisation a base de composes de xenon, et procedes de production de difluorure et de trioxyde de xenon
WO2000064807A1 (fr) * 1999-04-27 2000-11-02 Milcitec Management S.A. Procede de production de difluorure de xenon et procede de purification de ce dernier
WO2000067806A1 (fr) * 1999-05-05 2000-11-16 Milcitec Management S.A. Agents de desinfection et de sterilisation a base de composes de xenon

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192016A (en) * 1962-12-18 1965-06-29 John G Malm Xenon hexafluoride and method of making
GB1056657A (en) * 1965-04-27 1967-01-25 Tech Gase Werke Berlin Veb Process for the preparation of fluorides of xenon and krypton
SU497222A1 (ru) * 1974-04-22 1975-12-30 Отделение ордена Ленина института химической физики АН СССР Способ получени перксенонатов
SU1560468A1 (ru) * 1988-03-09 1990-04-30 Институт Общей И Неорганической Химии Им.Н.С.Курнакова Ан Ссср Способ очистки дифторида ксенона
SU1699904A1 (ru) * 1989-11-04 1991-12-23 Отделение Института химической физики АН СССР Способ получени гексаоксоксеноната натри
SU1699903A1 (ru) * 1989-11-04 1991-12-23 Отделение Института химической физики АН СССР Способ получени водного раствора триоксида ксенона
RU2065488C1 (ru) * 1992-03-20 1996-08-20 Всесоюзный Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ Моющее средство для отмывки полимерной поверхности и способ отмывки
WO2000064495A1 (fr) * 1999-04-27 2000-11-02 Aleinikov, Nikolai Nikolaevich Agents de desinfection et de sterilisation a base de composes de xenon, et procedes de production de difluorure et de trioxyde de xenon
WO2000064807A1 (fr) * 1999-04-27 2000-11-02 Milcitec Management S.A. Procede de production de difluorure de xenon et procede de purification de ce dernier
WO2000067806A1 (fr) * 1999-05-05 2000-11-16 Milcitec Management S.A. Agents de desinfection et de sterilisation a base de composes de xenon

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HATANO, K.: "Fluorine-18 labeling of methionine derivatives in the presence of Xenon difluoride", CHEM. PHARM. BULL., vol. 46, no. 8, 1998, pages 1337 - 1338 *
MILDRED K. BUENING ET AL.: "Fluorine substitution as a probe for the role of the 6-position of Benzopyrene in Carcinogenesis 1,2,3", J. OF THE NATL. CANCER INST., vol. 71, 1983, pages 309 - 315 *

Also Published As

Publication number Publication date
AU2001236259A1 (en) 2002-05-15
RU2232711C1 (ru) 2004-07-20

Similar Documents

Publication Publication Date Title
CN101189017B (zh) 在牙科应用中使用氧化还原电位水溶液的方法
CH701627B1 (de) Verfahren zur Herstellung einer Zusammensetzung von Hypochlorsäure und deren Anwendungen.
WO1983002892A1 (fr) Preparation medicinale possedant un effet antinicotine et son procede d'obtention
CN106074692A (zh) 一种复方稳定性二氧化氯溶液及其制备方法和应用
Reddy et al. Chlorine and the Chemistry of Disinfectants: A Fascinating Journey—18th Century to the COVID Times
Dun Veterinary Medicines Their Actions and Uses
Da Costa Modern surgery, general and operative
Blyth A dictionary of hygiene and public health
WO2002036488A1 (fr) Procede de fabrication d'oxygene et de composes fluores du xenon et leur utilisation
RU2243151C2 (ru) Способ получения кислородных соединений ксенона и их использование
EP0348507A4 (en) Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis
CN111603425B (zh) 一种多功能皮肤消毒清洁液泡腾片及其制备方法
RU2243152C2 (ru) Способ получения комплекса гексафторида ксенона с трифторидом бора и его использование
Tapia et al. Ozone therapy and its scientific foundations
Altman The New Oxygen Prescription: The Miracle of Oxidative Therapies
Green Oxygenation therapy unproven treatments for cancer and AIDS
CN104206414A (zh) 用于清洗红光治疗仪的消毒液及其制备方法
Dock Text-book of materia medica for nurses
Sircus Healing With Iodine: Your Missing Link To Better Health
Evers Foundation for Alternative Science & Technology Bio-oxidative therapies
Da Costa Modern surgery, general and operative
Sircus Sodium Bicarbonate
WO2000067806A1 (fr) Agents de desinfection et de sterilisation a base de composes de xenon
Vale et al. The Second European Symposium on Paraquat Poisoning, 27th January 1986, Guy's Hospital, London
UA145445U (uk) Засіб для дезінфекції

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase